Tradestie Institutional Equity Comparison Engine

PTN vs OGEN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PTN Overall Edge

PTN Captures Institutional Edge (2โ€“1 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Palatin Technologies, Inc. (PTN) driven by superior Valuation, Momentum & Technical while OGEN counters with relative strength in Growth & Margin. Fundamentally, PTN trades at 42.9x Forward P/E with -65.7% operating margin (-80.1% YoY revenue) versus OGEN at N/M Forward P/E and 0.0% operating margin (-91.3% YoY). In options structure, PTN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against OGEN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner PTN
PTN 42.9x vs OGEN N/M Fwd P/E
Growth & Margin Winner OGEN
Op Margin -65.7% vs 0.0% ยท YoY -80.1% vs -91.3%
Momentum & Technical Winner PTN
1Y -43.3% vs -82.6% ยท 52W Pos 6% vs 3%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
PTN US Equity
Palatin Technologies, Inc.
Pharmaceutical Preparations
$6.12
-1.69% 1D
Market Cap $11.1M
1M Return +1.74%
1Y Return -43.29%
Forward P/E 42.9x
Unified AI Score
31.5 / 100 SELL
Tech 15.0 Fund 30.0 Flow 50.0 Mom 40.0
OGEN NYSE American
Oragenics Inc.
Pharmaceutical Preparations
$0.20
-1.49% 1D
Market Cap $906,903
1M Return -54.47%
1Y Return -82.63%
Forward P/E N/M
Unified AI Score
38.8 / 100 SELL
Tech 25.0 Fund 46.0 Flow 50.0 Mom 75.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PTN -43.29% OGEN -82.63% Spread: +39.34 pp (PTN Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period PTN Revenue OGEN Revenue PTN Op. Margin OGEN Op. Margin Margin Edge
FY2018 $70M N/A 38.6% N/A PTN
FY2019 $60M N/A 59.3% N/A PTN
FY2020 $0M N/A -20007.6% N/A PTN
FY2021 N/A $0M N/A -18130.3% OGEN
FY2022 $0M $0M -2491.6% -10964.6% PTN
FY2023 $0M $0M -668.7% -55519.9% PTN
FY2024 $0M N/A -501.0% N/A PTN
FY2026 $10M N/A -65.7% N/A PTN

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PTN (7) vs OGEN (3)
Institutional Metric PTN OGEN Criterion Row Winner
Market Capitalization Scale $11.1M $906,903 Larger Scale PTN
Trailing P/E Ratio Valuation 42.9x N/M Lower Multiple PTN
Forward P/E Ratio Valuation 42.9x N/M Lower Multiple PTN
Revenue Growth (YoY) Growth -80.1% -91.3% Higher Growth PTN
Operating Margin (TTM) Profitability -65.7% 0.0% Higher Margin OGEN
Net Profit Margin Profitability -63.5% 0.0% Higher Margin OGEN
Return on Equity (ROE) Capital Efficiency -877.5% -1307.1% Higher ROE PTN
52-Week Range Position Momentum 6% ($5โ€“$31) 3% ($0โ€“$1) Stronger Trend PTN
Beta / 30D Volatility Risk Regime 0.87ฮฒ ยท 106% Vol 1.19ฮฒ ยท 153% Vol Lower Realized Risk PTN
Unified Institutional Score Composite Signal 31.5 / 100 (SELL) 38.8 / 100 (SELL) Higher Composite OGEN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PTN vs OGEN Buy Guide
PTN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PTN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
OGEN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live OGEN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PTN nor OGEN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.